Literature DB >> 17615580

CD5+ B cells with the features of subepithelial B cells found in human tonsils.

Mariella Dono1, Vito Lelio Burgio, Monica Colombo, Salvatore Sciacchitano, Daniele Reverberi, Vincenzo Tarantino, Giovanna Cutrona, Nicholas Chiorazzi, Manlio Ferrarini.   

Abstract

This study describes a CD5+ B cell that differs from the majority of the CD5+ B cells from human tonsils. This cell, isolated from in vivo activated B cells, expressed activation markers and featured a CD23-, IgMhigh, IgDlow surface phenotype, responded to T cell-independent type-2 antigens in vitro, and was detected in the subepithelial (SE) areas, the tonsil equivalent of the splenic marginal zone (MZ). Most of the cells utilized unmutated Ig VH genes, although cells with mutated genes also were found, a finding confirmed by single-cell studies. Mutated sequences were more frequent in suspensions enriched for CD27+ cells. Repeated VDJ gene sequences were observed in different molecular clones from the same cell suspension, suggesting in situ expansion. These CD5+ B cells seem to share features with previously characterized tonsil CD5- SE B cells and differ from the majority of tonsil CD5+ B cells, which have the surface phenotype of follicular mantle B cells, lack activation markers, do not respond to T cell-independent antigens, and utilize unmutated VH genes. These data are discussed considering the present views on the origin of B cell subset populations and the relationships between MZ and B1 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615580     DOI: 10.1002/eji.200636887

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

2.  Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Authors:  Rosa Catera; Gregg J Silverman; Katerina Hatzi; Till Seiler; Sebastien Didier; Lu Zhang; Maxime Hervé; Eric Meffre; David G Oscier; Helen Vlassara; R Hal Scofield; Yifang Chen; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2008-09-25       Impact factor: 6.354

3.  KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.

Authors:  Lynn M Hassman; Thomas J Ellison; Dean H Kedes
Journal:  J Clin Invest       Date:  2011-01-18       Impact factor: 14.808

4.  Purification and identification of cell surface antigens using lamprey monoclonal antibodies.

Authors:  Cuiling Yu; Shabab Ali; Jonathan St-Germain; Yanling Liu; Xuecong Yu; David L Jaye; Michael F Moran; Max D Cooper; Götz R A Ehrhardt
Journal:  J Immunol Methods       Date:  2012-09-04       Impact factor: 2.303

5.  Expression of immunoglobulin receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen.

Authors:  Monica Colombo; Giovanna Cutrona; Daniele Reverberi; Silvia Bruno; Fabio Ghiotto; Claudya Tenca; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Jenny Ceccarelli; Sandra Salvi; Simona Boccardo; Maria Grazia Calevo; Amleto De Santanna; Mauro Truini; Franco Fais; Manlio Ferrarini
Journal:  Mol Med       Date:  2013-09-17       Impact factor: 6.354

Review 6.  The pathogenesis of chronic lymphocytic leukemia.

Authors:  Suping Zhang; Thomas J Kipps
Journal:  Annu Rev Pathol       Date:  2013-08-26       Impact factor: 23.472

7.  FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Shouluan Ding; Jicun Pan; Mikhail A Shakhmatov; Elena Kashentseva; Jiongru Wu; Yufeng Li; Seng-jaw Soong; Nicholas Chiorazzi; Randall S Davis
Journal:  Blood       Date:  2008-02-26       Impact factor: 22.113

8.  Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.

Authors:  Silvia Catellani; Ivana Pierri; Marco Gobbi; Alessandro Poggi; Maria Raffaella Zocchi
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

9.  Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.

Authors:  Anders Rosén; Ann-Charlotte Bergh; Peter Gogok; Chamilly Evaldsson; Anna Lanemo Myhrinder; Eva Hellqvist; Abu Rasul; Magnus Björkholm; Mattias Jansson; Larry Mansouri; Anquan Liu; Bin Tean Teh; Richard Rosenquist; Eva Klein
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

10.  Cellular origin and pathophysiology of chronic lymphocytic leukemia.

Authors:  Marc Seifert; Ludger Sellmann; Johannes Bloehdorn; Frederik Wein; Stephan Stilgenbauer; Jan Dürig; Ralf Küppers
Journal:  J Exp Med       Date:  2012-10-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.